|
|
||||||||
Department of Anesthesiology, Duke University Medical Center, Box 3094 DUMC, Durham, NC 27710
(Email: staff002@mc.duke.edu).
| The first 20% of the full text of this article appears below. |
Management guidelines for the perioperative angiotensin-converting enzyme inhibitors (ACEIs) are increasingly needed, as their use becomes more prevalent in patients presenting for cardiac surgery, and studies report experimental evidence for protective effects with short-term therapy with these agents. The ACEIs have their actions on the renin-angiotensin system (RAS), a signaling pathway that mediates systemic vasoconstriction, but has an equally important role in the local regulation of renal microcirculatory flow. Paradoxically, RAS blockade can
Related Article
Ann. Thorac. Surg. 2008 86: 1160-1165.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |